Substances like CJC-1293, CJC-1295, sermorelin and tesamorelin, anamorelin, capromorelin, ibutamoren (MK-677), ipamorelin, lenomorelin (ghrelin), macimorelin, tabimorelin, GHRPs
FDA has also identified five (5) additional peptide and peptide-derived substances, including Cathelicidin LL-37, Dihexa acetate, GHK-Cu (injectable), Mechano Growth Factor (PEG-MGF), and Melanotan II, for removal from Category 2 and for later consultation with the PCAC at an advisory committee meeting expected before February 2027
Antigen-specific peptide therapies that induce immune tolerance to myelin proteins represent perhaps the most elegant approach to MS treatment
Evidence suggests possible gene reset mechanisms are involved, though this remains under study
There are better evidence-based options and lifestyle tweaks that can help with the concerns that these trendy peptides claim to fix